Stay updated on PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial
Sign up to get notified when there's something new on the PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial page.

Latest updates to the PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedNo significant changes detected; the update appears to involve minor formatting and layout adjustments on the Study Details page without altering core study information (eligibility criteria, endpoints, or enrollment details). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check32 days agoChange Detected- Added a government funding notice with operational details and links; - Updated version to v3.2.0; - Removed reference to v3.1.0.SummaryDifference2%

- Check39 days agoChange DetectedUpdated version to v3.1.0 and added multiple contact emails and phone numbers; older version reference v3.0.2 was removed.SummaryDifference0.0%

- Check53 days agoChange DetectedShift to Revision: v3.0.2 is now present; the previous v3.0.1 and the Back to Top link were removed. No other substantive content changes were detected.SummaryDifference0.1%

- Check60 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.1%

- Check68 days agoChange DetectedThe web page has added significant content related to cancer topics, including specific areas like 'Tumors and Pregnancy' and 'Cancer in Children', while removing several location-related details and references to previous resources.SummaryDifference2%

Stay in the know with updates to PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PEGPH20 & Pembro in High Metastatic PDAC Clinical Trial page.